BNV Biolab

What BNV Biolab does

BNV Biolab is a privately held South Korean biotechnology company founded in 2014 and headquartered in Geumcheon-gu, Seoul. The firm has developed a proprietary regenerative protein technology platform, branded G4PRF-300, designed to treat tissue malfunctions by initiating and completing the wound-healing process in targeted dermis and epidermis, with research findings published in SCI and KCI journals. The company operates in the medical aesthetics and regenerative personal care space, serving aesthetic clinics, plastic surgery centers, hair restoration clinics, and women's health clinics in South Korea, alongside a smaller direct-to-consumer home-care customer base.

The commercial portfolio is organized along two channels. The clinic channel (At Clinics) sells regenerative protein formulations — WMPF (vaginal), HMPF (hair/scalp), SMPF (skin), BNV EXO (exosome-based skin), and Dermafactor — to a network of 988+ aesthetic and plastic surgery clinics across Seoul, Busan, Incheon, and Gwangju. The home-care channel (At Home) sells complementary consumer SKUs — WMPF at home, Dermafactor at home, BNV Lip Ointment, BNV MPF Mask, and BNV Total Care Solution — through the company's global e-commerce storefront. A three-tier partner program (Personal, Professional, Partner) and a Private Label / OEM service layer B2B manufacturing and distribution on top of the direct product sales.

The business is founder-controlled, with no disclosed institutional investors, funding rounds, parent company, or external capital structure. The representative director is Seo Seong-hoon (서성훈), and the company appears to operate with limited disclosed headcount and no publicly available revenue figures. Pricing for products is not publicly disclosed. Beyond the Korean clinic footprint, the company advertises global distribution and e-commerce capabilities, but no overseas clinic installations or foreign distributor revenue is documented in the available sources.

Name

BNV Biolab

Legal name

비엔뷔바이오랩 (주)

Website

https://bnvbiolab.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

BNV Biolab is a privately held South Korean biotech firm that develops and sells proprietary regenerative protein products (WMPF, HMPF, SMPF, BNV EXO, Dermafactor) to a 988+ clinic aesthetic-medicine network in South Korea and complementary home-care SKUs via global e-commerce.

Ownership category

akta.pro rank

Product category

Regenerative Biotechnology

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), Pharmaceutical Preparation Manufacturing (325412)

SIC

Biological Products, (No Disgnostic Substances) (2836), Perfumes, Cosmetics & Other Toilet Preparations (2844)

akta.pro industry

PRIMARYHLAAAGAG

Wound Healing & Skin Regeneration (advanced dressings, skin substitutes)

Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering

SECONDARYHLAGABAC

Biologics (mAbs/Recombinant Proteins) CDMO

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)

Keywords

• Regenerative protein technology
• Aesthetic medicine products
• Skin regeneration treatment
• Wound healing formulations
• Biopharmaceutical cosmetics

Headquarters

HQ city

Seoul

HQ country

South Korea

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Operations, Personnel, Marketing or Sales, Supply Chain

Revenue model

1. Clinical Products: Sale of regenerative protein products (WMPF, HMPF, SMPF, BNV EXO, Dermafactor) directly to aesthetic clinics for patient treatments.
2. Home Care Products: Consumer products for home use including WMPF, BNV Lip Ointment, Dermafactor, BNV MPF Mask, and BNV Total Care Solution sold through e-commerce.
3. Private Label / OEM Services: Manufacturing and branding services for partners seeking to offer BNV's regenerative technology under their own brand names.
4. Distributor Partnerships: Distribution of BNV products through a network of authorized distributors for broader geographic reach.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

Core offering

BNV Biolab develops, manufactures, and sells regenerative protein products built on its proprietary G4PRF-300 technology platform, which initiates and completes the wound healing process in targeted dermis and epidermis. The company offers clinical-grade regenerative treatments (WMPF, HMPF, SMPF, BNV EXO, Dermafactor) for use at aesthetic clinics covering skin, scalp, vaginal, and lip tissue regeneration, alongside a parallel line of home-care consumer products. It also operates a private label/OEM service for partners who want to distribute the technology under their own brand.

Product overview

BNV Biolab is a regenerative biotechnology company that has developed proprietary regenerative protein technology (G4PRF-300) designed to heal and remodel targeted dermis and epidermis by initiating and completing the wound healing process. The product portfolio consists of clinical-grade treatments (WMPF, HMPF, SMPF, BNV EXO, Dermafactor) available at aesthetic clinics, and corresponding home care products (WMPF, Dermafactor, BNV Lip Ointment, BNV MPF Mask, BNV Total Care Solution) for ongoing maintenance. The company also offers private label and OEM/ODM services for partners. Current solutions address skin, scalp, vagina, and lips.

Differentiator

Problem solved

Functional benefit

Brands

• WMPF: Regenerative protein complex product for vaginal treatment at clinics
• HMPF
• SMPF
• BNV EXO
• Dermafactor
• BNV MPF Mask
• BNV Lip Ointment
• BNV Total Care Solution

Products and services

• WMPF (Clinical) Regenerative protein complex formulation for vaginal tissue regeneration and repair, designed for use at aesthetic clinics.
• HMPF (Clinical) Hair regeneration protein complex formulation for scalp treatment, designed for use at aesthetic clinics.
• SMPF (Clinical) Skin regeneration protein formulation for dermis and epidermis repair, designed for clinical use at aesthetic clinics.
• BNV EXO (Clinical) Exosome-based regenerative treatment product for skin applications at aesthetic clinics.
• Dermafactor (Clinical) Complex formulation for skin regeneration and repair, designed for professional clinical use at aesthetic clinics.
• WMPF (At Home) Home care version of the WMPF wound healing formulation for vaginal tissue maintenance and care, sold to individual consumers.
• BNV Lip Ointment Lip care product formulated with regenerative proteins for lip tissue repair, sold for home use to individual consumers.
• Dermafactor (At Home) Home care version of the Dermafactor complex for ongoing skin regeneration maintenance, sold to individual consumers.
• BNV MPF Mask Regenerative protein mask for at-home skin care and treatment maintenance, sold to individual consumers.
• BNV Total Care Solution Comprehensive at-home skin care system combining multiple regenerative treatments, sold to individual consumers.
• Private Label / OEM Service OEM/ODM private label manufacturing and branding service for clinics, distributors, and partners wanting to offer BNV regenerative products under their own brand.

Named customers9 records

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Nine partnerships are on record, tiered minor.

• 111 Medical Office (111 의원)minorChannel Partner/ Reseller/ DistributorAesthetic clinic in Seoul Gangnam district using BNV SMPF products for skin treatments. Located at S-TOWER, Dosan-daero 111.
• 815 Medical Office (815 의원)minorChannel Partner/ Reseller/ DistributorAesthetic clinic using BNV Dermafactor products for skin treatments. Located at Rodem Building, Nonhyeon-ro 822 in Gangnam.
• BLS Clinic Main Branch (BLS의원 본점)minorChannel Partner/ Reseller/ DistributorAesthetic clinic using BNV products. Located at BLS Clinic Building, Dosan-daero 67-gil 13-5 in Gangnam.
• JW Jung Won-seong Plastic Surgery (JW 정원성형외과의원)minorChannel Partner/ Reseller/ DistributorPlastic surgery clinic using BNV products. Located at JW Plastic Surgery Building, Samsung-ro 553 in Gangnam.
• K Plastic Surgery Hospital (K성형외과병원)minorChannel Partner/ Reseller/ DistributorPlastic surgery hospital in Busan using BNV products. Located at Hwangnyeong-daero 12, Busan Jin-gu.
• MH Medical Office (MH 의원)minorChannel Partner/ Reseller/ DistributorMedical office using BNV products. Located at Rolls-Royce Auto Building, Apgujeong-ro 445 in Gangnam.
• SM Mi-seong Plastic Surgery (SM미성형외과의원)minorChannel Partner/ Reseller/ DistributorPlastic surgery clinic in Gwangju using BNV products. Located at Sangmu Tower, Sangmu Jungang-ro 7.
• ST Sungmo Dermatology (ST성모피부과의원)minorChannel Partner/ Reseller/ DistributorDermatology clinic using BNV products. Located at Bongeunsa-ro 469 in Gangnam.
• CnB Clear and Beautiful Main Branch (CnB맑고고운본점의원)minorChannel Partner/ Reseller/ DistributorAesthetic clinic in Incheon using BNV HMPF products for hair treatments. Located at Michuhol-daero 610, Michuhol-gu, Incheon.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Medipost: Korean-listed stem cell therapy company with regenerative medicine products (Cartistem, Cupistem) targeting orthopedic and broader indications. Adjacent incumbent in Korean regenerative medicine with deeper capital base and regulatory experience relevant to BNV's positioning.

Direct peers

• AnteAGE: US regenerative aesthetics brand offering growth factor-based serums and professional products to clinics and consumers. Comparable to BNV in dual-channel (clinical + home care) regenerative protein positioning targeting skin rejuvenation outcomes.
• BENEV Company Inc. US-based regenerative aesthetics company offering growth factor and exosome-based professional and home care products to medical spas and aesthetic clinics. Closely comparable to BNV in dual clinical/consumer GTM, protein-based regenerative technology, and SCI-backed positioning.
• ExoCoBio: Korean exosome company developing exosome-based regenerative aesthetics and dermatology products for clinical and consumer markets. Highly comparable to BNV as a Korean-headquartered exosome regenerative aesthetics peer with overlapping clinic distribution strategy.
• Rion Aesthetics: US-based aesthetics company specializing in platelet-derived growth factor and exosome regenerative products sold to medical aesthetics providers. Directly comparable to BNV in protein/exosome regenerative technology targeting aesthetic clinics and consumer channels.
• Kimera Labs: US exosome-focused regenerative company developing exosome products for aesthetics, wellness, and recovery applications. Comparable to BNV's BNV EXO product line and broader regenerative positioning in aesthetics market.
• Prostemics: Korean regenerative aesthetics company offering exosome-based skin and hair regenerative products to clinics and consumers. Directly comparable to BNV as a Korean peer with exosome/protein regenerative offerings in aesthetic medicine channels.

Regional players

• Pharmicell: Korean cell therapy and regenerative medicine company developing stem cell-based therapeutics. Comparable as a Korean-headquartered regenerative medicine peer, though focused on broader therapeutic indications rather than aesthetics specifically.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/bnv-biolab

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BNV Biolab